GZD824 Dimesylate
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT) and Bcr-Abl (T315I) .
Product Specifications
CAS Number
1421783-64-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
724.77
Molecular Formula
C29H27F3N6O·2CH4O3S
Notes
Research use only, not for human use.
Receptor
Abl| Abl (E255K) | Abl (H396P) | Abl (M351T) | Abl (Q252H)
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2118130-01 0.1 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details 
MBS2118130-02 0.2 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details 
MBS2118130-03 0.5 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details MBS2118130-04 1 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details MBS2118130-05 5 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details 
MBS2118130-06 5x 5 mL
PE-Linked Polyclonal Antibody to Transforming Growth Factor Beta 2 (TGFb2)
Ask
View Details